nharbeck

Professor Nadia Harbeck is a full professor and head of the breast center at the University of Munich, Germany. She also heads the Oncological Therapy and Clinical Trials Unit at the University Dept. of OB&GYN in Munich. She received her Medical Degree from the University of Munich (LMU). From 2009-2011, she was head of the breast center at the University of Cologne. Until 2009, she was Associate Professor and head of Conservative Senology at Technical University of Munich, where she also obtained her specialist degree in Obstetrics and Gynecology in 1998. Professor Harbeck is a member of the expert panel issuing the yearly updated evidence-based AGO Guidelines for breast cancer therapy in Germany (www.ago-online.org).
Prof. Harbeck has been active in the EORTC since the mid 1990’s in several positions. Currently, she is EORTC executive board member and steering committee member of the EORTC PathoBiology Group. She is also member of numerous other professional organizations including ASCO, ESMO, AACR. Professor Harbeck is co-chair of the West German Study Group (WSG, a BIG member). She is principal investigator or steering committee member of numerous national and international breast cancer trials, with a recent focus on novel targeted compounds. She is member of the international TransHERA as well as co-chair of the TransALTTO committee. Her translational research focuses on prognostic and predictive factors in breast cancer and other solid tumors, in particular on using biomarkers for therapy decisions within clinical trials.
Professor Harbeck has authored more than 260 papers in peer-reviewed journals (cumulative impact factor > 1000) and, in addition to serving on editorial boards (e.g. Journal of Clinical Oncology) or as a reviewer (e.g. Annals of Oncology) for several scientific journals and grant-giving agencies (e.g. German Cancer Aid), she is coordinating Editor-in-Chief of Breast Care. She also serves on the organizing committee for numerous national and international clinical and translational cancer meetings. For her clinical translational research, she has received numerous awards, including a 2001 AACR award, the 2001 ASCO Fellowship Merit Award for the highest ranking abstract submitted and the 2002 AGO Schmidt-Matthiesen Award. In honour of her scientific achievements, Prof. Harbeck was invited to give the Emmanuel van der Schueren Lecture at the European Breast Cancer Conference (EBCC) 6 in Berlin 2008 and the Opening Lecture at IBCM-2 in Sarajevo 2009. In 2011, she co-chaired the 3rd IMPAKT meeting (Brussels) and the EORTC-NCI-ASCO Annual Meeting on Molecular Markers in Cancer (Brussels).